A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Any adult patient with active systemic cancer diagnosed with acute ischemic stroke at the
main MSKCC campus or any of MSKCC's New York City outpatient centers within the prior two
weeks would be eligible.
Interventional
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Safety Outcomes
The primary safety outcomes will consist of intracranial hemorrhage, symptomatic intracranial hemorrhage, major bleeding, and death.
6 months
Yes
Lisa DeAngelis, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
12-264
NCT01763606
December 2012
December 2014
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
Memorial Sloan-Kettering Cancer Center at Commack | Commack, New York 11725 |
Memorial Sloan-Kettering at Basking Ridge | Basking Ridge, New Jersey 07920 |